Stephen Chanock Elected to the 2023 Class of AAAS Fellows
, by Jennifer K. Loukissas, M.P.P.
Stephen J. Chanock, M.D., Director of the Division of Cancer Epidemiology and Genetics (DCEG) was recognized as a Fellow of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and publisher of the Science family of journals.
Dr. Chanock is one of 502 scientists, engineers, and innovators who have been elected for their scientifically and socially distinguished achievements throughout their careers. He was honored for “distinguished contributions to the field of epidemiology and genomics, particularly using Genome-Wide Association Studies (GWAS), and for his staunch leadership in the Division of Cancer Epidemiology and Genetics, NCI.”
Dr. Chanock came to the NCI in 2001 as a tenured investigator in the Genomic Variation Section of the Pediatric Oncology Branch in the Center for Cancer Research; he joined DCEG in 2007 as chief of the Laboratory of Translational Genomics. From 2012 to 2013, he also served as Acting Co-Director of the NCI Center for Cancer Genomics and was appointed Director of DCEG in 2013. He is a leading expert in the discovery and characterization of cancer susceptibility regions in the human genome and has received numerous awards for his scientific contributions to our understanding of common inherited genetic variants associated with cancer risk and outcomes.
A tradition dating back to 1874, election as an AAAS Fellow is a lifetime honor, and all Fellows are expected to maintain the highest standards of professional ethics and scientific integrity. Distinguished past honorees include W.E.B. DuBois, Ellen Ochoa, Steven Chu, Grace Hopper, Alan Alda, and Mae Jemison.